Publication & Citation Trends
Most Cited Works
Publications
22 total
Dose response of umeclidinium administered once or twice daily in patients with COPD: A pooled analysis of two randomized, double‐blind, placebo‐controlled studies
Cited by 16
OpenAlex
A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD
Cited by 65
OpenAlex
Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
Cited by 187
OpenAlex
Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations PDF
Cited by 246
OpenAlex
Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: Response by beta-agonist reversibility
Cited by 54
OpenAlex
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma
Cited by 59
OpenAlex
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study
Cited by 32
OpenAlex
A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD
Cited by 54
OpenAlex
Research Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
(15)
Asthma and respiratory diseases
(13)
Receptor Mechanisms and Signaling
(6)
Respiratory and Cough-Related Research
(6)
Pharmacological Effects and Assays
(4)
Frequent Co-Authors
Affiliations
University of North Carolina at Chapel Hill
Albert Einstein College of Medicine
Research Triangle Park Foundation
Yeshiva University
University of Florida